Literature DB >> 22385136

Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome.

Irina Kowalska1, Agnieszka Adamska, Maciej T Malecki, Monika Karczewska-Kupczewska, Agnieszka Nikolajuk, Magdalena Szopa, Maria Gorska, Marek Straczkowski.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder where insulin resistance might be involved in the development of endocrine and metabolic abnormalities. It has recently been shown that the FTO gene modifies weight, fat mass and insulin sensitivity in women with PCOS, where its role might be larger than in other phenotypes.
OBJECTIVE: The aim of this study was to estimate the effect of a variation of the FTO gene on carbohydrate and lipid oxidation in PCOS women. PATIENTS: The study group consisted of 65 women with PCOS and 28 healthy, normally menstruating women. MEASUREMENTS: Clinical examination, anthropometric measurements, euglycaemic hyperinsulinaemic clamp and measurements of serum sex hormones were performed. Carbohydrate and lipid oxidation were evaluated with indirect calorimetry in the baseline state and during last 30 min of the clamp. The FTO rs9939609 polymorphism was genotyped using the restriction fragment length polymorphism method.
RESULTS: There were no differences in carbohydrate and lipid oxidation between PCOS and control women. In the PCOS group, TT homozygotes had higher baseline fat oxidation in comparison with carriers of the A allele (P = 0·018), which was not found in the control group. We did not observe the effect of the FTO gene variation on insulin-stimulated lipid oxidation and neither on the baseline nor on the insulin-stimulated carbohydrate oxidation.
CONCLUSION: Our data show that this FTO gene variation might influence the baseline lipid oxidation in PCOS patients. This might potentially be one of the mechanisms explaining the impact of the FTO gene on body weight in PCOS.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385136     DOI: 10.1111/j.1365-2265.2012.04379.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

Review 1.  The 'Fat Mass and Obesity Related' (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance.

Authors:  John R Speakman
Journal:  Curr Obes Rep       Date:  2015-03

2.  Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis.

Authors:  Qianwen Liu; Zhaozhong Zhu; Peter Kraft; Qiaolin Deng; Elisabet Stener-Victorin; Xia Jiang
Journal:  BMC Med       Date:  2022-02-11       Impact factor: 8.775

3.  Emerging function of fat mass and obesity-associated protein (fto).

Authors:  Timo D Müller; Matthias H Tschöp; Susanna Hofmann
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

4.  BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case-control study.

Authors:  Yvonne V Louwers; Nigel W Rayner; Blanca M Herrera; Lisette Stolk; Christopher J Groves; Thomas M Barber; Andre G Uitterlinden; Stephen Franks; Joop S E Laven; Mark I McCarthy
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

5.  Relationships of serum soluble E-selectin concentration with insulin sensitivity and metabolic flexibility in lean and obese women.

Authors:  Agnieszka Adamska; Monika Karczewska-Kupczewska; Agnieszka Nikołajuk; Elżbieta Otziomek; Maria Górska; Irina Kowalska; Marek Strączkowski
Journal:  Endocrine       Date:  2013-08-10       Impact factor: 3.633

6.  Association between fat mass- and obesity-associated (FTO) gene polymorphism and polycystic ovary syndrome: a meta-analysis.

Authors:  Xianli Cai; Chibo Liu; Sihua Mou
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.